William W.L. Wong

Adjunct Scientist (Full Status) ICES Central Populations & Public Health Research Program

Biography

William W.L. Wong, Ph.D. is a decision modeller/health economist and an assistant professor at the School of Pharmacy, University of Waterloo. He is also a member of the Ontario Health Technology Advisory committee (OHTAC) for Ontario Health (Quality), where he served as a health economics modeling expert for the province. Dr. Wong’s research is focused on system-level policy modeling, infectious diseases modeling, health services and outcomes research, particularly in hepatitis B and C.

PhD, Computer Science, University of Waterloo

Health economics
Health technology assessment

Assistant Professor, School of Pharmacy, University of Waterloo

ICES Grants

Grant

2021 - 2022

Estimating chronic hepatitis B prevalence and the undiagnosed proportion in Canada using health administrative data

Granting Agency: Canadian Institutes of Health Research
Principal Investigators: Wong WWL
Co-Investigators: Feld JJ, Feng ZZ, Janjua NZ, Murti M, Sander BH
Grant Type: Catalyst Grant
Grant Amount: $100,000

See All

Awards & Recognition

14/05/2018

Early Researcher Award

2018: Awarded to William W.L. Wong by the Ministry of Research, Innovation and Science, Government of Ontario for the project "Developing policy models for viral hepatitis: integrating best evidence of effectiveness, safety, cost, and patient preferences."

See All

Journal Articles

Journal Article

22/03/2024

Validation of case-ascertainment algorithms using health administrative data to identify people who inject drugs in Ontario, Canada

Greenwald ZR, Werb D, Feld JJ, Austin PC, Fridman D, Bayoumi AM, Gomes T, Kendall CE, Lapointe-Shaw L, Scheim AI, Bartlett SR, Benchimol EI, Bouck Z, Boucher LM, Greenaway C, Janjua NZ, Leece P, Wong WWL, Sander B, Kwong JC. J Clin Epidemiol. 2024; Mar 22 [Epub ahead of print].

Journal Article

06/03/2024

Impact of new direct-acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection

Forouzannia F, Hamadeh A, Passos-Castilho AM, Erman A, Yu A, Feng Z, Janjua NZ, Sander B, Greenaway C, Wong WWL. Liver Int. 2024; Mar 6 [Epub ahead of print].

Journal Article

24/02/2024

Hepatitis C attributable healthcare costs and mortality among immigrants: a population-based matched cohort study

Erman A, Sahakyan Y, Everett K, Greenaway C, Janjua N, Kwong JC, Wong WWL, Lu H, Sander B. Can J Gastroenterol Hepatol. 2024; Feb 24 [Epub ahead of print].

Journal Article

08/09/2023

The impact of the early COVID-19 pandemic on healthcare system resource use and costs in two provinces in Canada: an interrupted time series analysis

Zeitouny S, Cheung DC, Bremner KE, Pataky RE, Pequeno P, Matelski J, Peacock S, Del Giudice ME, Lapointe-Shaw L, Tomlinson G, Mendlowitz AB, Mulder C, Tsui TCO, Perlis N, Walker JD, Sander B, Wong WWL, Krahn MD, Kulkarni GS. PLoS One. 2023; 18(9):e0290646. Epub 2023 Sep 8.

Journal Article

18/08/2023

A province-by-province cost-effectiveness analysis and budget impact analysis of one-time birth cohort screening of hepatitis C virus (HCV) infection in Canada

Wong WWL, Haines A, Wong J, Hamadeh A, Krahn MD. Sci Rep. 2023; 13(1):13484. Epub 2023 Aug 18.

Journal Article

09/08/2023

Engagement with the HCV care cascade among high-risk groups: a population-based study

Erman A, Everett K, Wong WWL, Forouzannia F, Greenaway C, Janjua N, Kwong JC, Sander B. Hepatol Commun. 2023; 7(9):e0222. Epub 2023 Aug 9.

Journal Article

11/04/2023

Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort study

Mendlowitz AB, Bremner KE, Krahn M, Walker JD, Wong WWL, Sander B, Jones L, Isaranuwatchai W, Feld JJ. CMAJ. 2023; 195(14):E499-512. Epub 2023 Apr 11.

Journal Article

20/09/2022

Initial healthcare costs for COVID-19 in British Columbia and Ontario, Canada: an interprovincial population-based cohort study

Tsui TCO, Zeitouny S, Bremner KE, Cheung DC, Mulder C, Croxford R, Del Giudice L, Lapointe-Shaw L, Mendlowitz A, Wong WWL, Perlis N, Sander B, Teckle P, Tomlinson G, Walker JD, Malikov K, McGrail KM, Peacock S, Kulkarni GS, Pataky RE, Krahn MD. CMAJ Open. 10(3):E818-30. Epub 2022 Sep 20.

Journal Article

05/05/2022

“Bring the hoses to where the fire is!”: differential impacts of marginalization and socioeconomic status on COVID-19 case counts and healthcare costs

Cheung DC, Bremner KE, Tsui TCO, Croxford R, Lapointe-Shaw L, Del Giudice L, Mendlowitz A, Perlis N, Pataky RE, Teckle P, Zeitouny S, Wong WWL, Sander B, Peacock S, Krahn MD, Kulkarni GS, Mulder C. Value Health. 2022; 25(8):1307-16. Epub 2022 May 5.

Journal Article

28/09/2021

Healthcare costs associated with hepatitis C virus infection in First Nations populations in Ontario: a retrospective matched cohort study

Mendlowitz A, Bremner KE, Walker JD, Wong WWL, Feld JJ, Sander B, Jones L, Isaranuwatchai W, Krahn M. CMAJ Open. 2021; 9(3):E897-906. Epub 2021 Sep 28.

See All

Contact Details

Get in touch with
William W.L. Wong

"*" indicates required fields

William W.L. Wong

Biography

Education

Research Focus

Other Affiliations

ICES Grants

Estimating chronic hepatitis B prevalence and the undiagnosed proportion in Canada using health administrative data

Awards & Recognition

Early Researcher Award

Journal Articles

Validation of case-ascertainment algorithms using health administrative data to identify people who inject drugs in Ontario, Canada

Impact of new direct-acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection

Hepatitis C attributable healthcare costs and mortality among immigrants: a population-based matched cohort study

The impact of the early COVID-19 pandemic on healthcare system resource use and costs in two provinces in Canada: an interrupted time series analysis

A province-by-province cost-effectiveness analysis and budget impact analysis of one-time birth cohort screening of hepatitis C virus (HCV) infection in Canada

Engagement with the HCV care cascade among high-risk groups: a population-based study

Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort study

Initial healthcare costs for COVID-19 in British Columbia and Ontario, Canada: an interprovincial population-based cohort study

“Bring the hoses to where the fire is!”: differential impacts of marginalization and socioeconomic status on COVID-19 case counts and healthcare costs

Healthcare costs associated with hepatitis C virus infection in First Nations populations in Ontario: a retrospective matched cohort study

Get in touch with
William W.L. Wong

William W.L. Wong

Biography

Education

Research Focus

Other Affiliations

ICES Grants

Estimating chronic hepatitis B prevalence and the undiagnosed proportion in Canada using health administrative data

Awards & Recognition

Early Researcher Award

Journal Articles

Validation of case-ascertainment algorithms using health administrative data to identify people who inject drugs in Ontario, Canada

Impact of new direct-acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection

Hepatitis C attributable healthcare costs and mortality among immigrants: a population-based matched cohort study

The impact of the early COVID-19 pandemic on healthcare system resource use and costs in two provinces in Canada: an interrupted time series analysis

A province-by-province cost-effectiveness analysis and budget impact analysis of one-time birth cohort screening of hepatitis C virus (HCV) infection in Canada

Engagement with the HCV care cascade among high-risk groups: a population-based study

Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort study

Initial healthcare costs for COVID-19 in British Columbia and Ontario, Canada: an interprovincial population-based cohort study

“Bring the hoses to where the fire is!”: differential impacts of marginalization and socioeconomic status on COVID-19 case counts and healthcare costs

Healthcare costs associated with hepatitis C virus infection in First Nations populations in Ontario: a retrospective matched cohort study

Get in touch with William W.L. Wong

Get in touch with
William W.L. Wong